A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologistinvolving extraction of sample cells or tissues for examination to determine the presence or extent of a disease. The tissue is generally examined under a microscope by a pathologist, and can also be analyzed chemically.
A needle biopsy is a procedure to obtain a sample of cells from your body for laboratory testing. Common needle biopsy procedures include fine-needle aspiration and core needle biopsy. Needle biopsy may be used to take tissue or fluid samples from muscles, bones, and other organs, such as the liver or lungs.

Market Analysis and Insights: Global Needle Biopsy Market
The global Needle Biopsy market size is projected to reach US$ 584.5 million by 2027, from US$ 426 million in 2020, at a CAGR of 4.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Needle Biopsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Needle Biopsy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Needle Biopsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Needle Biopsy market.

Global Needle Biopsy Scope and Market Size
Needle Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Needle Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Fine-Needle Aspiration Biopsy
Core Needle Biopsy
Vacuum-Assisted Biopsy
Image-Guided Biopsy

Segment by Application
Tumor
Infection
Inflammation

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boston Scientific
Cook Medical
Carefusion
Hologic
Cardinal Health
Medax
CR Bard
MöLler Medical
Becton, Dickinson And Company
Kompass
Hakko